Harlan Waksal Insider Trading $ELOX Eloxx Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Harlan Waksal.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Harlan Waksal. Harlan Waksal is Director in Sevion Therapeutics, Inc. ($SVON) and President, CEO in Kadmon Holdings, Inc. ($KDMN).

Harlan Waksal in Eloxx Pharmaceuticals, Inc.

Trading Symbol: ELOX
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Harlan Waksal: Director
Holdings: 822,168 shares
Current Value: $189,099
Latest Transaction: Nov 23 2015
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Harlan Waksal in Eloxx Pharmaceuticals, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ELOX, KDMN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 23 2015SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.5040,00020,00040,000
May 20 2015SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.9711,34011,000147,693
Feb 23 2015SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.5426,55214,338136,353
May 19 2011SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.2751,85214,0001,157,654
Feb 16 2011SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.2945,69013,2501,105,802
Nov 19 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.26500,000130,0001,060,112
Nov 19 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.26200,00052,000560,112
Nov 19 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.2696,15425,000360,112
Jun 03 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseP0.3220064200
Jun 03 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseP0.35625,000218,7501,167,333
May 27 2010SVONSevion Therapeutic ...Waksal HarlanDirectorBuyC0.83631,176523,876822,168191 K to 822.2 K (+330.47 %)
May 27 2010SVONSevion Therapeutic ...Waksal HarlanDirectorGrantA0.5112,0786,202190,992178.9 K to 191 K (+6.75 %)
May 27 2010SVONSevion Therapeutic ...Waksal HarlanDirectorGrantA0.3728,13510,334178,914150.8 K to 178.9 K (+18.66 %)
May 24 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.6122,95114,000263,958
Feb 23 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseP0.8387,31372,470542,333
Feb 23 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseP0.83130,969108,704455,020
Feb 23 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseP1.0187,31388,186324,051
Feb 23 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseP1.01130,969132,279236,738
Feb 23 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseP1.0178,58179,367105,769
Feb 23 2010SVONSevion Therapeutic ...Waksal HarlanDirectorBuyP0.00135,7790150,77915 K to 150.8 K (+905.19 %)
Feb 23 2010SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.2977,50022,475241,007
Nov 23 2009SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.3970,00027,300163,507
Nov 23 2009SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.3966,92326,10093,507
Nov 23 2009SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.5919,49211,50026,584
Jul 31 2009SVONSevion Therapeutic ...Waksal HarlanDirectorBuyP0.0013,688027,18813.5 K to 27.2 K (+101.39 %)
Jul 31 2009SVONSevion Therapeutic ...Waksal HarlanDirectorBuyP0.0013,500013,5000 to 13.5 K
Jul 31 2009SVONSevion Therapeutic ...Waksal HarlanDirectorBuyP0.9015,00013,50015,0000 to 15 K
Feb 24 2009SVONSevion Therapeutic ...Waksal HarlanDirectorOption ExerciseA0.477,0923,3337,092

Page:   1